Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antifibrotic Activity of GI262570 in Chronic Hepatitis C
NCT00244751Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of farglitazar in hepatic fibrosis, sponsored by GSK. Started Nov 2005; status: completed.
02
Drugs
farglitazar
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on NCT00244751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244751.